InferMed Announces successful collaboration with Siemens

InferMed Ltd, the leading global provider of advanced decision support and data capture solutions for clinical research and practice, today announced that they have successfully completed the first year of study in conjunction with Siemens AG and researchers at the Technical University of Munich that enables an immediate, scalable method of automatically transferring data from an EMR to an EDC system, reducing lag time and greatly increasing efficiency.

Historically, the capture of clinical trial data has been labour intensive and error-prone, requiring data to be manually transcribed into a paper case report form or, more recently, entered manually into Internet-based data capture systems. This innovative solution from InferMed and Siemens offers a scalable, automatic transfer of data between the electronic medical record system and MACRO® EDC from InferMed thereby overcoming interoperability challenges previously associated with systems that operate on different technical platforms or work from within distinct business environments.

The pilot implementation was designed at the Technical University of Munich's Frauenklink to create an automatic electronic data transfer platform for two studies focusing on women's health. One of the studies was to evaluate the effectiveness of the various types of chemotherapy on women with breast cancer. The second study was to evaluate the diagnostic value of the use of motion correction algorithms on magnetic resonance imaging (MRI). By using this highly flexible solution, clinicians and research staff were able to automatically view, retrieve and disseminate clean data, while reducing the effort of manually collecting and entering trial data.

Preliminary results of the study show an increase of efficiency for all involved parties. Those improvements include quality improvement resultant from interfaces to all data demonstrating improved data quality and integrated processes leading to improved process quality.

The Technical University of Munich's Medical Center has proved attractive for both researchers and trial sponsors leading to greater numbers of such trials and therefore increased population results, all of which ultimately leads to improved patient care due to the many high-quality trials being conducted there.

Professor Harbeck, Principal Investigator at The Frauenklink commented that "The Technical University of Munich's academic medical center benefits greatly from using data from our existing clinical information system for clinical trial activities and we will continue to explore and use all relevant data sources at the medical center to support our clinical research activities. Complying with national and international data safety regulations, external clinical trial sponsors can now access higher quality data more quickly and in an electronic format."

"Having a solution that significantly improves study efficacy whilst enabling real-time data availability for clinical trial sites can only serve to revolutionise study management" said Duane Lawrence, CEO InferMed Ltd. He continued "enabling adaptive mid-trial alterations and ensuring consistency across study sites will eventually yield more timely and accurate outcomes. We are extremely proud to be part of this innovative solution that will ultimately benefit more timely and personalised patient care."

Dr. Gudrun Zahlmann, the project lead from Siemens AG, Healthcare sector said that "This innovative solution has proven to be efficient in reducing the time effort of the study nurses for data documentation to one third compared to the old paper-based process. All clinical trial related data is available within 24 hours in a high quality, clean format and in accordance with the regulatory requirements. We have found two highly motivated and very reliable partners in the Frauenklinik of the Technical University Munich and in InferMed Ltd. This relationship together with the innovative and challenging solution made this pilot a success. This could prove to be the blueprint for the overall EHR – EDC integration for clinical trials."

About InferMed Ltd
Formed in 1999 InferMed is the leading global provider of advanced decision support and data capture solutions for clinical research and practice. InferMed offers a range of highly innovative software solutions for collecting and managing data. Through both their MACRO EDC application and Arezzo® decision support technology, InferMed’s products are designed to improve patient outcomes and deliver personalised drug and other therapies to healthcare providers. For more information visit www.infermed.com.

About The Technical University of Munich
The Technical University of Munich's Rechts der Isar hospital serves Munich and the world with a highly skilled team of dedicated doctors, nurses, research scientists, and technical assistants. With a workforce of over 3,700 personnel, the University hospital is a renowned center for the care of the sick, for medical research, and for the teaching of medicine. Rechts der Isar comprises more than 31 separate clinics and departments treating some 45,000 inpatients and 160,000 outpatients annually. Its department of obstetrics and gynecology, under the guidance of Prof. Dr. Marion Kiechle and her team is a certified breast center and is heavily involved in clinical research and clinical trials to bring innovative procedures to the patient, such as uPA/PAI measurements for chemotherapy decision support.

A 1,100-bed hospital, Rechts der Isar covers the entire spectrum of modern medicine with state-of-the-art efficiency. Through the close cooperation between healthcare and research, the latest advances in medical techniques can be quickly integrated into patient treatment procedures.

About Siemens Healthcare
Siemens Healthcare is one of the world's largest suppliers to the healthcare industry. The company is a renowned medical solutions provider with core competence and innovative strength in diagnostic and therapeutic technologies as well as in knowledge engineering, including information technology and system integration. With its laboratory diagnostics acquisitions, Siemens Healthcare will be the first fully integrated diagnostics company, bringing together imaging and lab diagnostics, therapy, and healthcare information technology solutions, supplemented by consulting and support services. Siemens Healthcare delivers solutions across the entire continuum of care - from prevention and early detection, to diagnosis, therapy and care. The company employs more than 49,000 people worldwide and operates in 130 countries. In the fiscal year 2007 (Sept. 30), Siemens Healthcare reported sales of €9.85 billion (on a pro forma basis including Dade Behring roughly €11 billion), orders of €10.27 billion, and group profit of €1.32 billion. Further information can be found by visiting http://www.siemens.com/healthcare.

Most Popular Now

Is Your Marketing Effective for an NHS C…

How can you make sure you get the right message across to an NHS chief information officer, or chief nursing information officer? Replay this webinar with Professor Natasha Phillips, former...

Welcome Evo, Generative AI for the Genom…

Brian Hie runs the Laboratory of Evolutionary Design at Stanford, where he works at the crossroads of artificial intelligence and biology. Not long ago, Hie pondered a provocative question: If...

We could Soon Use AI to Detect Brain Tum…

A new paper in Biology Methods and Protocols, published by Oxford University Press, shows that scientists can train artificial intelligence (AI) models to distinguish brain tumors from healthy tissue. AI...

Telehealth Significantly Boosts Treatmen…

New research reveals a dramatic improvement in diagnosing and curing people living with hepatitis C in rural communities using both telemedicine and support from peers with lived experience in drug...

Research Study Shows the Cost-Effectiven…

Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection fraction, than without AI. New study findings...

AI can Predict Study Results Better than…

Large language models, a type of AI that analyses text, can predict the results of proposed neuroscience studies more accurately than human experts, finds a new study led by UCL...

New Guidance for Ensuring AI Safety in C…

As artificial intelligence (AI) becomes more prevalent in health care, organizations and clinicians must take steps to ensure its safe implementation and use in real-world clinical settings, according to an...

Remote Telemedicine Tool Found Highly Ac…

Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as accurate in identifying skin cancers as having a dermatologist examine them in person, a...

Philips Aims to Advance Cardiac MRI Tech…

Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic announced a research collaboration aimed at advancing MRI for cardiac applications. Through this investigation, Philips and Mayo Clinic will look to...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Deep Learning Model Accurately Diagnoses…

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: Cardiothoracic...

Shape-Changing Device Helps Visually Imp…

Researchers from Imperial College London, working with the company MakeSense Technology and the charity Bravo Victor, have developed a shape-changing device called Shape that helps people with visual impairment navigate...